Aspicor 300

Valsts: Armēnija

Valoda: angļu

Klimata pārmaiņas: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Lietošanas instrukcija Lietošanas instrukcija (PIL)
11-09-2015
Produkta apraksts Produkta apraksts (SPC)
11-09-2015

Aktīvā sastāvdaļa:

acetylsalicylic acid

Pieejams no:

Coral Laboratories Ltd.

SNN (starptautisko nepatentēto nosaukumu):

acetylsalicylic acid

Deva:

300mg

Zāļu forma:

tablets gastro-resistant

Receptes veids:

OTC

Lietošanas instrukcija

                                Ргеsсri
ption
iv{eLiicine
Оп
ly
AýpIroR
300
Oastro-
resistant
Aspirin ]'ablets
300
nrg
Ргорriеtаry
Nаmе
ASPICOR
300
International
Nоп-Рrорriеtаry
Na
me
Gastro-
гesistattt
Aspirin Tablets
300
mg
}osage
fоrпr
:
Епtегiс
coated tablet
tЬr
сrгаl
use.
DescriptioIr
:
White
соlоurеd.
гоuпd.
lэiсопчех,
епtеriс
coated tablets
plain
on
both
the
sides.
Composition:
Еасh
entgric
c*ated tablgt
contains
:
Aspirin
З00
mg
Excipicnts
q.s.
Соlоur
:
Titaniunr
Dioxide
List
of
excipieпts
:
Аsрiгirl
(i)irссrlу
СопrрrеssiЬlе
Сгапuiеs).
Steaiic
Acici,
I)uriireci
'i'alc,
IsоргоруI
Alcohol,
Dichloronrethane,
Micгocrystaliirre
Cellulose,
(lrоsсаrmеllоsе
Scrdium,
ColIoidal
Апhусlrоus
Silica,
Cellulose
Acetate
Phthalate, Titanir.rm
DioKide.
Clinical
Рhаrmасоlоgу
}'harnrcological
Grorrp
:
]
;\n
tithrоm
botic
аgеп
ts,
plrrtelet
aggгegatiOn
inh
i
bi
tогs
excl.
hераri
п.
АТС
code:
NO2BAOl
Pharmacod,vnamics
:
Aspirin
is
arr
anti-inflammatory
analgesic
апd
antipyretic.
Aspirin
is
analgesic,
a1,1ti-inflammatory,
апtiругеtiс
and
аrr
inhibitor
of
platelet
aggregation"
It
prolongs
the bleeding time.
it
inhibits
f'atty
acid
cyclo-oxygenase
Ьу
acetylation of
the
active
site
of
the
enzyme"
atrcl
most
of
irs
рhагmасоlоgiсаl
eflects
аrе duе to
inhibition of
the
formatioll
of
cyclo-oxygenase
ргоduсts
inc!uding
tirromboxanes,
prostaglandins
and
prostacyclin"
The
еffесt
orr
platelets
is cumrrlativ8 очеr
their 8-day
life
span because
they
have
по
capacity to
resy-nthesize
tlre
cyclo-oxygenase enzyme,
Aspiгin
has ап active
metabolite
(salicylale)
rvhich,
iп
acidition
to
possessing
some
anti-int]arrnratory
ргореrtiеs
in its
orvn
rig}rt.
also has
in-rportant
еflЪсts
оп
rеsрiгаtiоп.
acid-base
balance апd thе stonraclr.
Salicylates
stimulate геsрirаtiоп
Ьу а
direct
ef}bct
оп
tlre
medu|la,
and
at
high
crincentratirrns,
uпсоuрlе
oxidative
рhоsрhогуlаtiоп
in
muscle,
iп
                                
                                Izlasiet visu dokumentu
                                
                            

Produkta apraksts

                                Н
fi,;il
l
iл*:iiJr;ilit,i
lllj
]
V
i
lýЁ
i.]'{t.';,']ri;:ii;
11,,
[;
;';r:
:;,:'
l,
тýýý
ýýеýý{л&]Lý4*щiýI}чс11]
{хцмст]ý[.t
"
,,
N;rяп*
of the
зnetIiciп:tl
рrоtluсt
:
Тrаtl*
Наýls
:
AýP1COR
З00
}оsе
;
30t}
rng
I}os:tge
fоrпt
;
Епrсгiс
coatcd
t;.r}rlet
lоr
огаl
use,
со:прlеtе
Qualitrrtive
anil
Quantit:rtive
cornposition
of
the
protluct
Comptrsition:
Each
е::ti:гi*
coated
iabl*t
coritains
:
Дsрiriп
З00
rпg
Excipients
q,s"
сtllоttг
:
Тitапiulп
ýioxide
Г__._.-l-__
L_.
lPLrritiedTalc
I3.00
LuЬгiсr
-5
on
Аsрiгiп
{Diгесtiу
Compressible
Grапulеs)
j00.00
300"00
,0"lX)
6
Nt
iсr9сrу_siаl
}
ine
Cel
lu
lclse
10.00
7
сгоsсilrmеl
]osc
sodium
20.00
20,00
8
cnlloidnl
Апhчdгоus
sitiй
4,00
4.00
ýOlю
Total
350.00
-l5tl
!erlc
t):}Tlý
Uei
l
ul0ýe
Acelate
Plrthalate
.]
1.50
*--]l,л
**
0.S"
o_s,
l0
ii
lsоргор_уl
Al*ohol
/lc
DiсhIоrоmсt}rапе
q.S"
,а
Titaniuлr
Dioxide
?in
2.5
0
ГБl
л__
r
:&r
{
ся
tl
l
rдпдll*яrs
lr,l
]
V.]
;jC
i:;{i]rt
ii,ii;;]:i
}:],''11;ýýj
\./
3"
I}htrtпасеutiсаl
Forrrt
,
..
t
,i
т*,.,1
l
alrtctS
clinical
p:lrticutars
4.1
Theraptrrtic
Indications
r\-spirin
has
analgesic,
at,ltipyretic
апt!
апti-iпflа*зrп;ltоry
actioxs,
{t
is
ind;catgd
Гс}r:
"
The
relicf
оf
heлdache.
'оothachc,
шigrаiпе,
пешrаlgiа"
sоrе
thгоаt"
clysltlettorriэoea,
l
The
sYmptol:ratic
r*]igf
of' irif'Iuenza,
ltvcгishness,
гheuilratic
;ltin.s,
sci*ti*a.
lttlлbago.
tiЬrositis,
mrrs*ulаг
*ch*s
anrj
раills,
,
lt
also
has ап
antithгcmbotic
aclion,
mec]iated
tllrorrgh
inhibitioп
oгplatelet
activation.
rvhich
has
Ье*п
shоwп
to
Ье
uscfirl
in
secondary
рrорhуlа.чis
l'ollolvir:g
ml,осагdiаl
irribгctirlli-
and
in
patients
rvith
unstabie
angina
апсl
cerelrral
tгапsiспl
ischerrlic
attacks
{.2
,Роsоltgу
&
r-lcthtrrl
of
Adnrinistr*fiort
Aiirlils
irlclrtJing
clJcriy-:
1-2
iJlclgis
{З00-600mg)
ечегу
)-.i
htluгs
as
rссlLriгеd,
{cr
;r
пlахiпruпr
                                
                                Izlasiet visu dokumentu
                                
                            

Meklēt brīdinājumus, kas saistīti ar šo produktu

Skatīt dokumentu vēsturi